1. Home
  2. BARK vs VNDA Comparison

BARK vs VNDA Comparison

Compare BARK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

HOLD

Current Price

$0.66

Market Cap

115.2M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.23

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BARK
VNDA
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
289.0M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BARK
VNDA
Price
$0.66
$6.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$2.50
$14.00
AVG Volume (30 Days)
709.6K
1.3M
Earning Date
11-10-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$451,690,000.00
$212,074,000.00
Revenue This Year
N/A
$12.01
Revenue Next Year
$5.02
$21.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.12
52 Week Low
$0.63
$3.81
52 Week High
$2.32
$6.88

Technical Indicators

Market Signals
Indicator
BARK
VNDA
Relative Strength Index (RSI) 40.15 63.55
Support Level $0.63 $4.89
Resistance Level $0.70 $6.88
Average True Range (ATR) 0.03 0.39
MACD 0.00 0.16
Stochastic Oscillator 34.88 70.10

Price Performance

Historical Comparison
BARK
VNDA

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: